Completed PHASE4 INTERVENTIONAL 2-arm NCT00460538

Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms

Sponsor: Milsing d.o.o.

Updated 5 times since 2017 Last updated: Apr 2, 2010 Started: Apr 30, 2007 Primary completion: Oct 31, 2007 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00460538, this PHASE4 trial focuses on Seasonal Allergic Rhinitis and remains completed. Sponsored by Milsing d.o.o., it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Milsing d.o.o.

Data source: Milsing d.o.o.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zagreb, Croatia